Why Microbiology Testing Solutions?
Diagnostics play a fundamental role in the healthcare chain to detect infectious agents, determine the right treatment, and monitor patients' evolution. They make a genuine impact on the quality of care while contributing to the sustainability of healthcare systems. Microbiology diagnostics provide key and sometimes critical information at multiple points along the healthcare continuum, from risk assessment and early diagnosis to treatment, patient follow-up, and disease management.
Microbiology diagnostic tests are designed to directly detect disease-causing agents and determine microorganism resistance to specific treatments like antibiotics. Labs need solutions that ensure accurate diagnostic test results to help determine the treatment to be prescribed by a healthcare professional. Clinicians need to know whether they must escalate or de-escalate with more appropriate antibiotics.
Microbiology testing plays a vital role in monitoring the emergence and spread of antimicrobial-resistant agents. Antimicrobial resistance is recognized as a major threat to public health by many governments, international organizations (such as the World Health Organization), and health experts.1 This is a top priority for the United Nations. Preserving drug efficacy for future generations through appropriate use of antimicrobial drugs is critical.
What challenges are hospital and service labs currently facing?
Our hospital and service labs play a critical role in overall public health worldwide, especially considering 60% to 70% of medical decisions are based on diagnostics.2 As our ageing population grows and the need for 24/7 services increases, our laboratories are faced with a variety of challenges that impact their day-to-day activities. Labs often receive high volumes of samples that need to be processed quickly and accurately, because patients and healthcare providers expect timely results. Reducing turnaround times while maintaining accuracy can be demanding. This increased workflow combined with the financial and medical pressures for faster delivery of results creates a daily burden on the lab.
The ever-increasing need for antimicrobial stewardship programs is critically important at the lab level. They need to make sure protocols align with current guidelines and recommendations. Labs need to consistently monitor resistance and make sure they are offering optimized testing by selecting the most appropriate diagnostic tests to identify the causative agents and their susceptibility patterns. Labs will encounter financial constraints and technological limitations, all of which can impact their ability to deliver efficient, timely, and reliable services and results.
How can our Microbiology Testing solutions help?
Microbiology testing solutions from bioMérieux provide rapid diagnostic solutions to enable targeted therapy faster, to increase survival rate in the case of sepsis, and/or to sustain antibiotic efficiency. Our microbiology portfolio offers the most comprehensive diagnostic choice to meet laboratory needs worldwide:
- Pioneering innovation to improve lab efficiency and medical value
- High quality products with excellent biological performances and time-to-result
- An integrated approach to increase the diagnostic value
- Trusted partner with proven track record on services, support, and supply who is committed to reducing our carbon and environmental footprint
- Tailored approach, modular and adapted to any situation, lab configuration, and budget
- Global company that can answer global purchasing departments and international tenders
- Solutions designed by microbiologists for microbiologists
Why partner with bioMérieux for Microbiology Testing Solutions?
A world leader in the field of in vitro diagnostics for over 60 years, bioMérieux is present in 45 countries and serves more than 160 countries through a large network of distributors. bioMérieux provides diagnostic solutions (systems, reagents, software, and services) that determine the origin of a disease to improve the health of patients.
Our broad range of products and services can be tailored to any lab’s situation, budget, and environment. Our experience in lab optimization, rapid diagnostics, IT, and data analytics will ensure that together we will identify the right suite of solutions to meet the needs of our customers.
- Offering exceptional solutions in terms of performance and quality
- Meeting the needs of any lab configuration from small labs to large lab chains
- Supplying solutions that abide to microbiology protocols from regular specimens like urine samples to precious samples such as blood culture or cerebrospinal fluid
- Offering comprehensive integrated solutions
Disclaimer: Product availability varies by country. Please consult your local bioMérieux representative for product availability in your country.
Our Microbiology Testing Offer
Our comprehensive microbiology testing offer is built upon our commitment to developing innovative solutions, staying ahead of microorganism evolutions, and contributing to the ongoing fight against emerging infectious diseases and antimicrobial resistance.
We are committed to flexibly meeting the needs of any lab with our extensive range of high quality, cost-effective culture media. Our culture products allow our customers to obtain easy-to-read, rapid results, whatever the quantity and type of microorganism in the specimen.
-
WASP®
Automated Microbiology Specimen Processing Instrument
Quality diagnostic results depend on high standard specimen processing. WASP® is the smart solution for truly comprehensive automation – taking you far beyond plating and streaking to address all aspects of microbiology specimen processing.
WASP® System is manufactured by COPAN Company. -
WASPLab®
Integrated Lab Optimization and Automation
The flexible automated specimen processing, incubation, and reading solution that adapts to your unique lab setup and workflow – and even grows with you over time.
WASPLab® System is manufactured by COPAN Company. -
Liquid Based Microbiology – LBM®
Universal Tubes for Liquid Sample Collection and Transport
Protect your sample quality with the unique LBM® range featuring a universal tube format for collection and transport, blood culture, sample pre-treatment and enrichment. This universal liquid-based multi-purpose system maintains viability of aerobes, anaerobes and fastidious bacteria for 48 hours.*
LBM® is manufactured by COPAN Company
-
BACT/ALERT® VIRTUO®
Automated System for Faster Blood Culture
The first fully automated blood culture system, helping to refine and redesign laboratory workflow to maximize efficiency, while providing the fastest clinically impactful results on the market.1,2
-
BACT/ALERT® 3D
Accurate Blood Culture Results
BACT/ALERT® 3D brings flexible and modular automated detection systems for any size laboratory that needs to meet blood culture guidelines efficiently, economically, and effectively.
-
BACT/ALERT® Culture Media Bottles
Innovative & Optimized Culture Media
BACT/ALERT® culture media offers a comprehensive range of media bottles to ensure the recovery of a wide variety of microorganisms including bacteria, mycobacteria, and fungi – including our next generation Fastidious Antimicrobial Neutralization Plus media (FAN® PLUS) offering optimized time to detection and recovery.
Differentiate, confirm, and identify microorganisms with confidence to provide fast, actionable results and support your antimicrobial stewardship goals.
-
PREVI® COLOR GRAM
A Market-Leading Automated Gram Stainer Offering Confidence in Results
Gram staining is a key step in your microbiology workflow, and PREVI® COLOR GRAM is the system to streamline it and provide timely staining results for impactful decisions.
-
BIOFIRE® Blood Culture Identification 2 Panel
1 Test. 43 Targets. ~1 Hour.
The BIOFIRE BCID2 Panel tests for 43 targets associated with bloodstream infections, including Gram-negative bacteria, Gram-positive bacteria, yeast, and 10 antimicrobial resistance genes – all with one test and with results available in about an hour from positive blood culture.
-
BIOFIRE® FILMARRAY® Meningitis/Encephalitis Panel
1 Test. 14 Targets. ~1 Hour.
The BIOFIRE ME Panel provides answers on 14 of the most common bacterial, viral, and yeast pathogens that cause central nervous system infections to help healthcare providers rapidly distinguish between bacterial and viral meningitis and optimize life-saving therapy.
-
VITEK® MS PRIME
New-Generation Mass Spectrometry Microbial Identification System
VITEK® MS PRIME combines microbiology expertise with innovation taking mass spectrometry to the next level by maximizing the impact of daily laboratory workflow for better patient care.
-
VITEK® MS
Microbial Identification in Minutes
VITEK® MS is an automated mass spectrometry microbial identification system that uses Matrix Assisted Laser Desorption Ionization Time-of-Flight (MALDI-TOF) technology.
-
VITEK® 2 ID & AST Cards
Rapid. Flexible. Efficient.
Providing accurate and reliable identification and antimicrobial susceptibility results for clinically relevant organisms with self-contained, disposable test cards designed for VITEK® 2 automated systems.
-
VITEK® 2
Fully integrated Identification and Antimicrobial Susceptibility Testing
VITEK® 2, the leading automated system for routine antimicrobial susceptibility testing, provides efficient workflow, faster AST results. Its fully-integrated ID & AST approach ensures superior performance to rapidly and confidently guide therapy.
-
VITEK® 2 COMPACT
Compact, automated ID/AST instrument
The compact solution for fast, accurate ID/AST testing with expert confidence
With our VITEK® 2 Systems, bioMérieux offers fully automated systems that perform both microbial identification and antibiotic susceptibility testing.
-
VITEK® 2
Fully integrated Identification and Antimicrobial Susceptibility Testing
VITEK® 2, the leading automated system for routine antimicrobial susceptibility testing, provides efficient workflow, faster AST results. Its fully-integrated ID & AST approach ensures superior performance to rapidly and confidently guide therapy.
-
VITEK® 2 COMPACT
Compact, automated ID/AST instrument
The compact solution for fast, accurate ID/AST testing with expert confidence
Of all the laboratory examinations performed daily by clinical microbiologists, antimicrobial susceptibility testing is of particular clinical importance. AST is a critical aid for selecting the most appropriate antimicrobial therapy for individual patients, monitoring the evolution of microbial resistance, and updating empirical therapeutic strategies.
-
VITEK® REVEAL™
Rapid Antimicrobial Susceptibility Testing (AST) for Bloodstream Infections
The newest addition to our Sepsis Solution, VITEK® REVEAL™ offers rapid AST results to effectively and efficiently manage bloodstream infections.
-
VITEK® 2 ID & AST Cards
Rapid. Flexible. Efficient.
Providing accurate and reliable identification and antimicrobial susceptibility results for clinically relevant organisms with self-contained, disposable test cards designed for VITEK® 2 automated systems.
From expert lab consultancy to automated instrument diagnostics and analytics, bioMérieux provides all the services and support to reach your antimicrobial stewardship goals.
-
VILINK®
Optimize Instrument UPTIME to Improve Laboratory Productivity
A secure solution offering remote access, proactive maintenance, and remote updates. VILINK® diagnoses, solves software and instrument issues, and supports your systems to enable laboratory productivity and efficiency improvements.
-
MAESTRIA™
New Generation Microbiology Middleware
An innovative, integrated software solution designed to orchestrate your lab routine and transform data into insights.
-
BIOMÉRIEUX LAB CONSULTANCY
Microbiology Expertise and Consultancy to Optimize Lab Performance
Transforming laboratories together to control costs, maximize quality, shorten time to result, and empower staff.
Useful Resources on Microbiology Testing
Contact Us About Our Microbiology Testing Offer
Contact Us
References
1. Antibiotic Resistance. World Health Organization. 2020. https://www.who.int/news-room/fact-sheets/detail/antibiotic-resistance
2. “60 to 70% of medical decisions are based on diagnostics” Source: the Lewin group inc. The value of diagnostics innovation, adoption, and diffusion into healthcare (July 2005)